{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:15:51Z","timestamp":1793952951725,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00192-019-04079-5","type":"journal-article","created":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T11:02:51Z","timestamp":1567854171000},"page":"35-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Latin American consensus on uncomplicated recurrent urinary tract infection\u20142018"],"prefix":"10.1007","volume":"31","author":[{"given":"Jorge Milhem","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Ubertazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Storme","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rodriguez-Colorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrain","family":"Toruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Katsumi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Castillo-Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,7]]},"reference":[{"key":"4079_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mda.2003.7","volume":"49","author":"B Foxman","year":"2003","unstructured":"Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49:53\u201370.","journal-title":"Dis Mon"},{"key":"4079_CR2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.eururo.2008.05.010","volume":"54","author":"KG Naber","year":"2008","unstructured":"Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008;54:1164\u201375.","journal-title":"Eur Urol"},{"key":"4079_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14737167.2017.1359543","volume":"18","author":"F Wagenlehner","year":"2018","unstructured":"Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. 2018;18:107\u201317.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"4079_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40121-014-0054-6","volume":"4","author":"J Renard","year":"2015","unstructured":"Renard J, Ballarini S, Mascarenhas T, et al. Recurrent lower urinary tract infections have a detrimental effect on patient quality of life: a prospective, observational study. Infect Dis Ther. 2015;4:125\u201335.","journal-title":"Infect Dis Ther"},{"key":"4079_CR5","unstructured":"Centre for Evidence-Based Medicine. Oxford Centre for Evidence-based Medicine \u2013 Levels of Evidence (March 2009). 2009. https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/ . Accessed 8 July 2019."},{"key":"4079_CR6","unstructured":"European Association of Urology. EAU Guidelines on Urological Infections 2011. 2011. http:\/\/uroweb.org\/wp-content\/uploads\/17_Urological-infections_LR-II.pdf . Accessed 8 July 2019."},{"key":"4079_CR7","unstructured":"European Association of Urology. EAU Urological Infections Guidelines 2019. 2019. https:\/\/uroweb.org\/guideline\/urological-infections\/ . Accessed 8 July 2019."},{"key":"4079_CR8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000486138","volume":"100","author":"J Kranz","year":"2018","unstructured":"Kranz J, Schmidt S, Lebert C, Schneidewind L, Mandraka F, Kunze M, et al. The 2017 update of the German clinical guideline on epidemiology, diagnostics, therapy, prevention, and management of uncomplicated urinary tract infections in adult patients: part 1. Urol Int. 2018;100:263\u201370.","journal-title":"Urol Int"},{"key":"4079_CR9","unstructured":"Tavares W, Lopes HV, Castro R, Poli M, Sartori M, Gir\u00e3o M, Lorenzetti F, Sim\u00f5es R. Cistite recorrente: tratamento e preven\u00e7\u00e3o. https:\/\/diretrizes.amb.org.br\/ans\/cistite_recorrente-tratamento_e_prevencao.pdf . Accessed 8 July 2019."},{"key":"4079_CR10","first-page":"S437","volume":"78","author":"M Del Pilar Velazquez","year":"2010","unstructured":"Del Pilar Velazquez M, Romero Nava LE, Lopez de Avalos DR, et al. Clinical practice guidelines. Recurrent infection of the urinary tract in women. Colegio Mexicano de Especialistas en Ginecolog\u00eda y Obstetricia. Ginecol Obstet Mex. 2010;78:S437\u201359.","journal-title":"Ginecol Obstet Mex"},{"key":"4079_CR11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.17116\/terarkh2016884100-104","volume":"88","author":"TS Perepanova","year":"2016","unstructured":"Perepanova TS. The 2015 federal clinical guidelines for antimicrobial therapy and prevention of infections of the kidney, urinary tract, and male genitals. Ter Arkh. 2016;88:100\u20134 (in Russian).","journal-title":"Ter Arkh"},{"key":"4079_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14777\/uti.2017.12.1.7","volume":"12","author":"SJ Lee","year":"2017","unstructured":"Lee SJ, Choe HS, Na YG, Kim KH, Kim JH, Chung H, et al. 2017 guidelines of the Korean association of urogenital tract infection and inflammation: recurrent urinary tract infection. Urogenit Tract Infect. 2017;12:7\u201314.","journal-title":"Urogenit Tract Infect"},{"key":"4079_CR13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/IAI.01000-09","volume":"78","author":"KE Sivick","year":"2010","unstructured":"Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun. 2010;78:568\u201385.","journal-title":"Infect Immun"},{"key":"4079_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309\u201332.","journal-title":"Am J Infect Control"},{"issue":"Suppl 1","key":"4079_CR15","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/clind\/15.Supplement_1.S216","volume":"15","author":"RH Rubin","year":"1992","unstructured":"Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992;15(Suppl 1):S216\u201327.","journal-title":"Clin Infect Dis"},{"key":"4079_CR16","unstructured":"Rubin RH, Shapiro ED, Andriole VT, Davies RJ, Stamm WE, with modifications by a European WorkingParty (Norrby SR). General guidelines for the evaluation of new anti-infective drugs for the treatment ofUTI. Taufkirchen, Germany: The European Society of Clinical Microbiology and Infectious Diseases,1993;294-310."},{"key":"4079_CR17","unstructured":"U.S. Department of Health and Human Services Center for Drug Evaluation and Research. Uncomplicated urinary tract infections: developing drugs for treatment guidance for industry. 2018. https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm607095.pdf . Accessed 8 July 2019."},{"key":"4079_CR18","unstructured":"U.S. Department of Health and Human Services Center for Drug Evaluation and Research. Complicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry 2018. 2018. https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070981.pdf . Accessed 8 July 2019."},{"key":"4079_CR19","unstructured":"European Association of Urology. EAU Guidelines on Urological Infections 2018. 2018 http:\/\/uroweb.org\/guideline\/urological-infections\/ . Accessed 8 July 2019."},{"key":"4079_CR20","unstructured":"European Association of Urology. EAU Guidelines on Urological Infections 2015. 2015. http:\/\/uroweb.org\/wp-content\/uploads\/EAU-Guidelines-Urological-Infections-v2.pdf . Accessed 8 July 2019."},{"issue":"1","key":"4079_CR21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.18597\/rcog.2981","volume":"68","author":"Mirna Luz Campo-Urbina","year":"2017","unstructured":"\u00a0Campo-Urbina ML, Ortega- Ariza N, Parody-Munoz A, Gomez- Rodriguez LDC. Caracterizaci\u00f3n y perfil de susceptibilidad de uropat\u00f3genos asociados a la presencia de bacteriuria asintom\u00e1tica en gestantes del departamento del Atl\u00e1ntico, Colombia, 2014-2015.Estudio de corte transversal. Rev Colomb Obstet Ginecol. 2017, 68 (1):62\u201370.","journal-title":"Revista Colombiana de Obstetricia y Ginecolog\u00eda"},{"key":"4079_CR22","first-page":"11","volume":"4","author":"E Ambuila Gonz\u00e1lez","year":"2015","unstructured":"Ambuila Gonz\u00e1lez E, Ram\u00edrez L\u00f3pez L, Escobar Bedoya A, Ch\u00e1vez Vivas M. Prevalencia de uropat\u00f3genos Gram negativo aislados de pacientes adultos en la ciudad de Cali. Ciencia Salud. 2015;4:11\u20137.","journal-title":"Ciencia Salud"},{"key":"4079_CR23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.36104\/amc.2014.270","volume":"39","author":"CP Orrego-Marin","year":"2014","unstructured":"Orrego-Marin CP, Henao-Mejia CP, Cardona-Arias JA. Prevalencia de infecci\u00f3n urinaria, uropat\u00f3genos y perfil de susceptibilidad antimicrobiana. Acta Medica Colombiana. 2014;39:352\u20138.","journal-title":"Acta Medica Colombiana"},{"key":"4079_CR24","first-page":"33","volume":"22","author":"E C\u00f3rdova","year":"2014","unstructured":"C\u00f3rdova E, Lespada MI, Cecchini D, et al. Prevalencia de g\u00e9rmenes multirresistentes en infecciones del tracto urinario de la comunidad y asociadas a los cuidados de la salud. Actual SIDA Infectol. 2014;22:33\u20138.","journal-title":"Actual SIDA Infectol"},{"key":"4079_CR25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","volume":"40","author":"LE Nicolle","year":"2005","unstructured":"Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40:643\u201354.","journal-title":"Clin Infect Dis"},{"key":"4079_CR26","doi-asserted-by":"crossref","first-page":"e015233","DOI":"10.1136\/bmjopen-2016-015233","volume":"7","author":"H Ahmed","year":"2017","unstructured":"Ahmed H, Davies F, Francis N, Farewell D, Butler C, Paranjothy S. Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and meta-analysis of randomised trials. BMJ Open. 2017;7:e015233.","journal-title":"BMJ Open"},{"issue":"Suppl","key":"4079_CR27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijantimicag.2011.09.009","volume":"38","author":"TE Johansen","year":"2011","unstructured":"Johansen TE, Botto H, Cek M, Grabe M, Tenke P, Wagenlehner FM, et al. Critical review of current definitions of urinary tract infections and proposal of an EAU\/ESIU classification system. Int J Antimicrob Agents. 2011;38(Suppl):64\u201370.","journal-title":"Int J Antimicrob Agents"},{"key":"4079_CR28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/cid\/cis534","volume":"55","author":"T Cai","year":"2012","unstructured":"Cai T, Mazzoli S, Mondaini N, Meacci F, Nesi G, D'Elia C, et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Clin Infect Dis. 2012;55:771\u20137.","journal-title":"Clin Infect Dis"},{"key":"4079_CR29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(05)74875-3","volume":"353","author":"A Stapleton","year":"1999","unstructured":"Stapleton A. Prevention of recurrent urinary tract infections in women. Lancet. 1999;353:7\u20138.","journal-title":"Lancet."},{"key":"4079_CR30","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/515283","volume":"177","author":"WJ Hopkins","year":"1998","unstructured":"Hopkins WJ, Heisey DM, Lorentzen DF, Uehling DT. A comparative study of major histocompatibility complex and red blood cell antigen phenotypes as risk factors for recurrent urinary tract infections in women. J Infect Dis. 1998;177:1296\u2013301.","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"4079_CR31","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1086\/318842","volume":"183","author":"R Raz","year":"2001","unstructured":"Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis. 2001;183(Suppl. 1):S74\u20136.","journal-title":"J Infect Dis"},{"key":"4079_CR32","first-page":"39","volume":"35","author":"A Basacopol","year":"1986","unstructured":"Basacopol A, Carantino A, Popescu C, Ambert L. Immunostimulation with a lyophilized bacterial lysate (Bronchovaxom) in patients with chronic suppurative processes of the respiratory tract. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1986;35:39\u201344.","journal-title":"Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol"},{"key":"4079_CR33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756287218814382","volume":"11","author":"O Storme","year":"2019","unstructured":"Storme O, Saucedo JT, Garcia-Mora A, Dehesa-D\u00e1vila M, Naber KG. Risk factors and predisposing conditions for urinary tract infection. Ther Adv Urol. 2019;11:19\u201328.","journal-title":"Ther Adv Urol"},{"key":"4079_CR34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199608153350703","volume":"335","author":"TM Hooton","year":"1996","unstructured":"Hooton TM, Scholes D, Hughes J, Winter C, Roberts PL, Stapleton AE, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335:468\u201374.","journal-title":"N Engl J Med"},{"key":"4079_CR35","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/315827","volume":"182","author":"D Scholes","year":"2000","unstructured":"Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182:1177\u201382.","journal-title":"J Infect Dis"},{"key":"4079_CR36","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1056\/NEJM198104303041802","volume":"304","author":"AJ Schaeffer","year":"1981","unstructured":"Schaeffer AJ, Jones JM, Dunn JK. Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary tract infections. N Engl J Med. 1981;304:1062\u20136.","journal-title":"N Engl J Med"},{"key":"4079_CR37","first-page":"268","volume":"25","author":"SJP Valdevenito","year":"2008","unstructured":"Valdevenito SJP. Infecci\u00f3n urinaria recurrente en la mujer. Rev Chil Infectol. 2008;25:268\u201376.","journal-title":"Rev Chil Infectol"},{"key":"4079_CR38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/CMR.00109-14","volume":"28","author":"L Cooling","year":"2015","unstructured":"Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015;28:801\u201370.","journal-title":"Clin Microbiol Rev"},{"key":"4079_CR39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/QCO.0000000000000127","volume":"28","author":"G Godaly","year":"2015","unstructured":"Godaly G, Ambite I, Svanborg C. Innate immunity and genetic determinants of urinary tract infection susceptibility. Curr Opin Infect Dis. 2015;28:88\u201396.","journal-title":"Curr Opin Infect Dis"},{"key":"4079_CR40","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJM199310283291808","volume":"329","author":"WE Stamm","year":"1993","unstructured":"Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328\u201334.","journal-title":"N Engl J Med"},{"key":"4079_CR41","first-page":"415","volume":"108","author":"FEM Wagenlehner","year":"2011","unstructured":"Wagenlehner FEM, Hoyme U, Kaase M, F\u00fcnfst\u00fcck R, Naber KG, Schmiemann G. Uncomplicated urinary tract infections. Dtsch Arztebl Int. 2011;108:415\u201323.","journal-title":"Dtsch Arztebl Int"},{"key":"4079_CR42","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5489\/cuaj.687","volume":"5","author":"S Dason","year":"2011","unstructured":"Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5:316\u201322.","journal-title":"Can Urol Assoc J"},{"key":"4079_CR43","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103\u201320.","journal-title":"Clin Infect Dis"},{"key":"4079_CR44","unstructured":"European Association of Urology. EAU Guidelines on Urological Infections Guidelines 2017. 2017. http:\/\/uroweb.org\/wp-content\/uploads\/19-Urological-infections_2017_web.pdf . Accessed 8 July 2019."},{"key":"4079_CR45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/iju.13493","volume":"25","author":"HS Choe","year":"2018","unstructured":"Choe HS, Lee SJ, Yang SS, et al. Summary of the UAA-AAUS guidelines for urinary tract infections. Int J Urol. 2018;25:175\u201385.","journal-title":"Int J Urol"},{"key":"4079_CR46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0924-8579(00)00350-2","volume":"17","author":"TM Hooton","year":"2001","unstructured":"Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259\u201368.","journal-title":"Int J Antimicrob Agents"},{"key":"4079_CR47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-5347(17)35648-3","volume":"150","author":"CC Schulman","year":"1993","unstructured":"Schulman CC, Corbusier A, Michiels H, Taenzer HJ. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol. 1993;150:917\u201321.","journal-title":"J Urol"},{"key":"4079_CR48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0924-8579(02)00106-1","volume":"19","author":"HW Bauer","year":"2002","unstructured":"Bauer HW, Rahlfs VW, Lauener PA, Blessmann GS. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents. 2002;19:451\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"4079_CR49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.eururo.2004.12.009","volume":"47","author":"HW Bauer","year":"2005","unstructured":"Bauer HW, Alloussi S, Egger G, et al. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol. 2005;47:542\u20138.","journal-title":"Eur Urol"},{"key":"4079_CR50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijantimicag.2008.08.011","volume":"33","author":"KG Naber","year":"2009","unstructured":"Naber KG, Chob YH, Matsumotoc T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents. 2009;33:111\u20139.","journal-title":"Int J Antimicrob Agents"},{"key":"4079_CR51","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.juro.2013.04.142","volume":"190","author":"MA Beerepoot","year":"2013","unstructured":"Beerepoot MA, Geerlings SE, van Haarst EP, van Charante NM, ter Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013;190:1981\u20139.","journal-title":"J Urol"},{"key":"4079_CR52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.acuro.2015.04.008","volume":"40","author":"KA Taha Neto","year":"2016","unstructured":"Taha Neto KA, Nogueira Castilhob L, Reisa LO. Oral vaccine (OM-89) in the recurrent urinary tract infection prophylaxis: a realistic systematic review with meta-analysis. Actas Urol Esp. 2016;40:203\u20138.","journal-title":"Actas Urol Esp"},{"key":"4079_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000189674","volume":"3","author":"M Meredith","year":"2009","unstructured":"Meredith M, Chiavaroli C, Bauer HG. Immunotherapy for recurrent urinary tract infections: effects of an escherichia coli extract. Curr Urol. 2009;3:1\u20138.","journal-title":"Curr Urol"},{"key":"4079_CR54","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/clinids\/14.4.810","volume":"14","author":"A Pfau","year":"1992","unstructured":"Pfau A, Sacks TG. Effective prophylaxis for recurrent urinary tract infections during pregnancy. Clin Infect Dis. 1992;14:810\u20134.","journal-title":"Clin Infect Dis"},{"key":"4079_CR55","first-page":"CD001209","volume":"3","author":"X Albert","year":"2004","unstructured":"Albert X, Huertas I, Pereir\u00f3 II, Sanf\u00e9lix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev. 2004;3:CD001209.","journal-title":"Cochrane Database Syst Rev"},{"key":"4079_CR56","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1371\/journal.pbio.0060280","volume":"6","author":"L Dethlefsen","year":"2008","unstructured":"Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.","journal-title":"PLoS Biol"},{"key":"4079_CR57","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","volume":"24","author":"GD Wright","year":"2016","unstructured":"Wright GD. Antibiotic adjuvants: rescuing antibiotics from resistance. Trends Microbiol. 2016;24:862\u201371.","journal-title":"Trends Microbiol"},{"key":"4079_CR58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.eimc.2016.11.005","volume":"35","author":"M De Cueto","year":"2017","unstructured":"De Cueto M, Aliaga L, Al\u00f3s JI, Canut A, Los-Arcos I, Mart\u00ednez JA, et al. Executive summary of the diagnosis and treatment of urinary tract infections: guidelines of the Spanish Society of Clinical Microbiology and Infections Diseases (SEIMC). Enferm Infecc Microbiol Clin. 2017;35:314\u201320.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"4079_CR59","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","volume":"329","author":"R Raz","year":"1993","unstructured":"Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329:753\u20136.","journal-title":"N Engl J Med"},{"key":"4079_CR60","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","volume":"180","author":"B Eriksen","year":"1999","unstructured":"Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol. 1999;180:1072\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"4079_CR61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/02813439209014051","volume":"10","author":"AL Kirkengen","year":"1992","unstructured":"Kirkengen AL, Andersen P, Gjers\u00f8e E, Johannessen GR, Johnsen N, Bodd E. Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. Scand J Prim Health Care. 1992;10:139\u201342.","journal-title":"Scand J Prim Health Care"},{"key":"4079_CR62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1471-0528.1998.tb10124.x","volume":"105","author":"L Cardozo","year":"1998","unstructured":"Cardozo L, Benness C, Abbott D. Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol. 1998;105:403\u20137.","journal-title":"Br J Obstet Gynaecol"},{"key":"4079_CR63","doi-asserted-by":"crossref","unstructured":"\u00a0Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.\u00a0Cochrane Database Syst Rev.\u00a02008;16:CD005131","DOI":"10.1002\/14651858.CD005131.pub2"},{"key":"4079_CR64","first-page":"CD001321","volume":"10","author":"RG Jepson","year":"2012","unstructured":"Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10:CD001321.","journal-title":"Cochrane Database Syst Rev"},{"key":"4079_CR65","first-page":"CD008772","volume":"12","author":"EM Schwenger","year":"2015","unstructured":"Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015;12:CD008772.","journal-title":"Cochrane Database Syst Rev"},{"key":"4079_CR66","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.juro.2017.03.078","volume":"198","author":"\u00c2 Lu\u00eds","year":"2017","unstructured":"Lu\u00eds \u00c2, Domingues F, Pereira L. Can cranberries contribute to reduce the incidence of urinary tract infections? A systematic review with meta-analysis and trial sequential analysis of clinical trials. J Urol. 2017;198:614\u201321.","journal-title":"J Urol"},{"key":"4079_CR67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12894-018-0342-7","volume":"18","author":"B Asma","year":"2018","unstructured":"Asma B, Vicky L, Stephanie D, Yves D, Amy H, Sylvie D. Standardised high dose versus low dose cranberry proanthocyanidin extracts for the prevention of recurrent urinary tract infection in healthy women [PACCANN]: a double blind randomised controlled trial protocol. BMC Urol. 2018;18:29.","journal-title":"BMC Urol"},{"key":"4079_CR68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00345-013-1091-6","volume":"32","author":"B Kranjcec","year":"2014","unstructured":"Kranjcec B, Pape\u0161 D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32:79\u201384.","journal-title":"World J Urol"},{"key":"4079_CR69","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.eururo.2010.12.039","volume":"59","author":"R Damiano","year":"2011","unstructured":"Damiano R, Quarto G, Bava I, et al. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol. 2011;59:645\u201351.","journal-title":"Eur Urol"},{"key":"4079_CR70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/nau.22256","volume":"32","author":"H Madersbacher","year":"2013","unstructured":"Madersbacher H, van Ophoven A, van Kerrebroeck PE. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans\u2014a review. Neurourol Urodyn. 2013;32:9\u201318.","journal-title":"Neurourol Urodyn"},{"key":"4079_CR71","doi-asserted-by":"crossref","unstructured":"Lee B, Bhuta T, Craig J, Simpson J. Methenaminahippurate for preventing urinary tract infections. Cochrane Database Syst Rev.2002; (1):CD003265\u00a0","DOI":"10.1002\/14651858.CD003265"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-019-04079-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-019-04079-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-019-04079-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T20:52:16Z","timestamp":1664311936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-019-04079-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,7]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4079"],"URL":"https:\/\/doi.org\/10.1007\/s00192-019-04079-5","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,7]]},"assertion":[{"value":"30 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JHM has received speaker fees from OM Pharma.EU has no relevant conflicts of interest to disclose.OSC has received speaker fees from OM Pharma.MM has no relevant conflicts of interest to disclose.JG has no relevant conflicts of interest to disclose.SRC has no relevant conflicts of interest to disclose.ET has no relevant conflicts of interest to disclose.PKM has no relevant conflicts of interest to disclose.ECP has received speaker fees from OM Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}